Jiemy, W.F. (2021). Macrophage diversity in the pathogenesis of vasculitides: implications for diagnosis and treatment [Groningen]: University of Groningen.
Zie ook website RUG
Proefschriften
Dekkema, G. (2020). Off balance: Regulatory and effector T cells in the pathogenesis of ANCA associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG
van Sleen, Y. (2020). Monocyte and macrophage heterogeneity in Giant Cell Arteritis and Polymyalgia Rheumatica: central in Pathology and a Source of Clinically Relevant Biomarkers. [Groningen]: University of Groningen.
Zie ook website RUG.
Hid Cadena, R. (2020). Immune checkpoint pathways in the ageing immune system and their relation to vasculitides. [Groningen]: University of Groningen.
Zie ook website RUG.
Hessels, A. (2019). Treatment outcomes in ANCA-associated vasculitis: Determinants of efficacy and toxicity. [Groningen]: University of Groningen.
Zie ook website RUG.
von Borstel, A. (2019). B cells in ANCA-associated vasculitides: from pathogenic players to biomarkers. [Groningen]: University of Groningen.
Zie ook website RUG.
Lintermans, L. L. (2019). Modulation of T and B cell function in Granulomatosis with polyangiitis: Targeting Kv1.3 potassium channels. [Groningen]: University of Groningen.
Zie ook website RUG.
Tuin, J. (2017). Consequences of disease and treatment in ANCA-associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG.
Wang, Q. (2016). Ageing of innate immunity in health and vasculitic diseases. [Groningen]: University of Groningen.
Zie ook website RUG.
Land, J. (2016). B cell phenotype and function in granulomatosis with polyangiitis: Towards prediction of relapse. [Groningen]: University of Groningen.
Zie ook website RUG.
de Joode, A. A. E. (2016). Improving clinical management in ANCA-associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG.
van der Geest, K. S. M. (2015). Senescence of the adaptive immune system in health and aging-associated autoimmune disease. [Groningen]: University of Groningen.
Zie ook website RUG.
Silva de Souza, A. (2015). High mobility group box-1 (hmgb1) in systemic vasculitides: The interplay with active disease, specific organ involvement and therapy. [Groningen]: University of Groningen.
Zie ook website RUG.
Lepse, N. (2014). The regulatory and effector functions of B cells in ANCA-associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG.
Tadema, H. (2011). Bacterial infection and ANCA-associated vasculitis: connecting mechanisms. [Groningen]: University of Groningen.
Zie ook website RUG.
van der Veen, B. S. (2010). Effector mechanisms of ANCA-associated glomerulonephritis. [Groningen]: University of Groningen.
Zie ook website RUG.
Sanders, J. S. F. (2009). Disease-activity in ANCA-associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG.
Heeringa, P. (1997). Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. [Groningen]: University of Groningen.
Zie ook website RUG.
Stegeman, C. A. (1995). Wegener’s granulomatosis: immunological and microbiological factors involved in disease activation. [Groningen]: University of Groningen.
Zie ook website RUG.
Brouwer, E. (1994). Pathologenis potential of antoneurophil cytoplasmai antibodies. [Groningen]: University of Groningen.
Zie ook website RUG.